Fiber optic device for sensing analytes

• US 7,792,561 B2
• Filed: 08/16/2007
• Issued: 09/07/2010
• Est. Priority Date: 11/26/2003
• Status: Expired due to Fees

• Current Assignee: Becton, Dickinson & Co
• Original Assignee: Becton, Dickinson & Co
• Inventors: Herdman, Christopher C., Jacobson, Ross Wayne, Denuzzio, John D., Alarcon, Javier, Sherman, Douglas B., Pitner, J. Bruce, Weidemaier, Kristin, Amiss, Terry J.
• Primary Examiner(s): Winakur; Eric F
• Assistant Examiner(s): Berhanu; Etsub D
• Application Number:
  US11/840,069
• Publication Number:
  US 20080198358A1
• Time in Patent Office: 1,118 Days
• Field of Search: 600/317, 600/322, 600/341, 600/342
• US Class Current: 600/317
• CPC Class Codes: G01N 21/7703 using reagent-clad optical fibres or optical waveguides using measurement of total internal reflection or attenuated total reflection G01N21/552; optical fibres or waveguides per se G02B
• CPC Class Codes: G01N 33/542 with steric inhibition or signal modification, e.g. fluorescent quenching
• CPC Class Codes: G01N 33/54373 involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings

Abstract

A device for sensing analyte concentration, and in particular glucose concentration, in vivo or in vitro is disclosed. An optical conduit, preferably an optical fiber has an optical system at the proximal end of the optical conduit. A sensing element is attached to the distal end of the optical conduit, and comprises at least one binding protein adapted to bind with at least one target analyte. The sensing element further comprises at least one reporter group that undergoes a luminescence change with changing analyte concentrations. Optionally, the sensing element includes reference groups with luminescence properties that are substantially unchanged by variations in the analyte concentrations.

Claims

1. A device for sensing a target analyte in a sample comprising:

(a) an optical fiber having a proximal end and a distal end;

(b) an optical system at the proximal end of the optical fiber comprising at least one electromagnetic energy emitter and at least one electromagnetic energy detector; and

(c) a sensing element attached to the distal end of the optical fiber and in optical connectivity with the optical fiber, the sensing element comprising (i) at least one periplasmic binding protein capable of specifically binding with at least one target analyte and at least one reporter group associated with the periplasmic binding protein and (ii) a polymeric matrix that is covalently and directly attached to said distal end of the optical fiber through reactive groups on the polymer, wherein the periplasmic binding protein and reporter group are entrapped within or attached to the polymeric matrix, wherein the matrix permits the periplasmic binding protein to retain conformational mobility, and wherein the matrix is adapted to transduce a luminescence change of the reporter group upon specific binding of the periplasmic binding protein to the target analyte.

2. The device of claim 1, further comprising a tip that houses and protects the optical fiber and the sensing element within the tip.

3. The device of claim 2, wherein the tip is selected from the group consisting of a needle and a catheter.

4. The device of claim 1, wherein the device comprises at least one reference group, and wherein the at least one reference group is associated with the at least one periplasmic binding protein.

5. The device of claim 1, wherein the sensing element is further adapted to be inserted into or through the skin of a patient.

6. The device of claim 1, wherein the periplasmic binding protein is a glucose-galactose binding protein.

7. The device of claim 1, wherein the target analyte is glucose.

8. The device of claim 1, wherein the optical fiber comprises a surface, wherein the surface of the optical fiber comprises amine groups, and wherein the reactive groups on the polymer covalently bond to the amine groups on the surface of the optical fiber.